ATE223232T1 - Tocopherolzusammensetzungen zur abgabe von biologisch aktiven substanzen - Google Patents
Tocopherolzusammensetzungen zur abgabe von biologisch aktiven substanzenInfo
- Publication number
- ATE223232T1 ATE223232T1 AT95921750T AT95921750T ATE223232T1 AT E223232 T1 ATE223232 T1 AT E223232T1 AT 95921750 T AT95921750 T AT 95921750T AT 95921750 T AT95921750 T AT 95921750T AT E223232 T1 ATE223232 T1 AT E223232T1
- Authority
- AT
- Austria
- Prior art keywords
- biologically active
- delivery
- active substances
- compositions
- tocopherol compositions
- Prior art date
Links
- 239000013543 active substance Substances 0.000 title abstract 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 229960001295 tocopherol Drugs 0.000 title abstract 2
- 229930003799 tocopherol Natural products 0.000 title abstract 2
- 235000010384 tocopherol Nutrition 0.000 title abstract 2
- 239000011732 tocopherol Substances 0.000 title abstract 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 title abstract 2
- 239000003995 emulsifying agent Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 210000000214 mouth Anatomy 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9409778A GB9409778D0 (en) | 1994-05-16 | 1994-05-16 | Compositions |
| PCT/EP1995/001835 WO1995031217A1 (en) | 1994-05-16 | 1995-05-15 | Tocopherol compositions for delivery of biologically active agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE223232T1 true ATE223232T1 (de) | 2002-09-15 |
Family
ID=10755206
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95921750T ATE223232T1 (de) | 1994-05-16 | 1995-05-15 | Tocopherolzusammensetzungen zur abgabe von biologisch aktiven substanzen |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6193985B1 (de) |
| EP (1) | EP0762896B1 (de) |
| AT (1) | ATE223232T1 (de) |
| CA (1) | CA2189328C (de) |
| DE (1) | DE69528057T2 (de) |
| DK (1) | DK0762896T3 (de) |
| ES (1) | ES2178674T3 (de) |
| FI (1) | FI119175B (de) |
| GB (1) | GB9409778D0 (de) |
| NO (1) | NO314569B1 (de) |
| NZ (1) | NZ287857A (de) |
| PT (1) | PT762896E (de) |
| WO (1) | WO1995031217A1 (de) |
Families Citing this family (118)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1129400A (zh) * | 1994-05-06 | 1996-08-21 | 阿尔康实验室公司 | 维生素e生育酚衍生物在眼科组合物中的应用 |
| GB2317562B (en) * | 1995-07-20 | 1999-08-18 | Danbiosyst Uk | Lipid vehicle drug delivery composition containing vitamin E |
| GB9514878D0 (en) * | 1995-07-20 | 1995-09-20 | Danbiosyst Uk | Vitamin E as a solubilizer for drugs contained in lipid vehicles |
| US5858401A (en) | 1996-01-22 | 1999-01-12 | Sidmak Laboratories, Inc. | Pharmaceutical composition for cyclosporines |
| ES2118033B1 (es) * | 1996-02-16 | 1999-07-01 | Bial Ind Farmaceutica S A | Formulacion farmaceutica antiinflamatoria. |
| US6730679B1 (en) | 1996-03-22 | 2004-05-04 | Smithkline Beecham Corporation | Pharmaceutical formulations |
| KR100472581B1 (ko) * | 1996-03-22 | 2005-06-16 | 글락소 그룹 리미티드 | Vx478과같은hiv프로테아제억제제및비타민e-tpgs와같은수용성비타민e화합물을포함하는조성물 |
| MY126358A (en) * | 1996-03-22 | 2006-09-29 | Glaxo Group Ltd | Compositions comprising vx478 and a water soluble tocopherol derivative such as vitamin e-tpgs |
| BR9708238A (pt) * | 1996-03-22 | 1999-08-03 | Glaxo Group Ltd | Formulação farmacêutica para administração oral e processo para preparar a mesma |
| US6284794B1 (en) * | 1996-11-05 | 2001-09-04 | Head Explorer Aps | Method for treating tension-type headache with inhibitors of nitric oxide and nitric oxide synthase |
| US6458373B1 (en) | 1997-01-07 | 2002-10-01 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
| US6727280B2 (en) | 1997-01-07 | 2004-04-27 | Sonus Pharmaceuticals, Inc. | Method for treating colorectal carcinoma using a taxane/tocopherol formulation |
| AU6919598A (en) * | 1997-04-17 | 1998-11-13 | Dumex-Alpharma A/S | A novel bioadhesive drug delivery system based on liquid crystals |
| US20040141923A1 (en) * | 1997-10-01 | 2004-07-22 | Dugger Harry A. | Buccal, polar and non-polar spray containing alprazolam |
| US7632517B2 (en) | 1997-10-01 | 2009-12-15 | Novadel Pharma Inc. | Buccal, polar and non-polar spray containing zolpidem |
| US20040136914A1 (en) | 1997-10-01 | 2004-07-15 | Dugger Harry A. | Buccal, polar and non-polar spray containing ondansetron |
| CA2320087C (en) * | 1998-02-09 | 2006-12-19 | Joel Bolonick | Treatment of chronic inflammatory disorders of the gastrointestinal tract |
| US7030155B2 (en) | 1998-06-05 | 2006-04-18 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
| US8466134B1 (en) * | 1998-06-26 | 2013-06-18 | Athena Neurosciences, Inc. | Aqueous compositions containing corticosteroids for nasal and pulmonary delivery |
| US5869704A (en) * | 1998-08-24 | 1999-02-09 | Eastman Chemical Company | Water-dispersible or water-soluble D-tocotrienol compounds and methods for making therefor |
| IL143197A0 (en) * | 1998-11-20 | 2002-04-21 | Rtp Pharma Inc | Dispersible phospholipid stabilized microparticles |
| US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| US20030236236A1 (en) * | 1999-06-30 | 2003-12-25 | Feng-Jing Chen | Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs |
| WO2001022937A1 (en) * | 1999-09-27 | 2001-04-05 | Sonus Pharmaceuticals, Inc. | Compositions of tocol-soluble therapeutics |
| RU2162699C1 (ru) * | 2000-02-14 | 2001-02-10 | Закрытое Акционерное Общество "Нита-Фарм" | Водно-дисперсная лекарственная форма ивермектина для лечения экто- и эндопаразитозов |
| US20040115133A1 (en) * | 2000-05-10 | 2004-06-17 | Wermeling Daniel P. | Intranasal opioid compositions |
| US20060083691A1 (en) * | 2000-05-10 | 2006-04-20 | Wermeling Daniel P | Intranasal opioid compositions, delivery devices and methods of using same |
| US6610271B2 (en) * | 2000-05-10 | 2003-08-26 | University Of Kentucky Research Foundation | System and method for intranasal administration of lorazepam |
| AU2001286518A1 (en) * | 2000-08-15 | 2002-02-25 | University Of Kentucky Research Foundation | Programmable multi-dose intranasal drug delivery device |
| AU2001293177A1 (en) * | 2000-09-27 | 2002-04-08 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
| AU2002214820B2 (en) * | 2000-11-14 | 2003-08-14 | Vital Health Sciences Pty Ltd | Formulation containing phosphate derivatives of electron transfer agents |
| US20040176359A1 (en) * | 2001-02-20 | 2004-09-09 | University Of Kentucky Research Foundation | Intranasal Benzodiazepine compositions |
| GB0114532D0 (en) * | 2001-06-14 | 2001-08-08 | Jagotec Ag | Novel compositions |
| GB0116107D0 (en) * | 2001-06-30 | 2001-08-22 | West Pharm Serv Drug Res Ltd | Pharmaceutical composition |
| GB0119480D0 (en) * | 2001-08-09 | 2001-10-03 | Jagotec Ag | Novel compositions |
| EP1423116A1 (de) * | 2001-08-14 | 2004-06-02 | Biotie Therapies Corp. | Verfahren zur behandlung von alkoholismus oder alkoholmissbrauch |
| US7586050B2 (en) * | 2001-09-07 | 2009-09-08 | Lashua John A | Ergonomic snow plow control system |
| US6858227B1 (en) | 2001-11-21 | 2005-02-22 | Sonus Pharmaceuticals, Inc. | Vitamin E conjugates |
| JP2005515996A (ja) * | 2001-12-03 | 2005-06-02 | ノバセア インコーポレイティッド | 活性型ビタミンｄ化合物を含む薬学的組成物 |
| AU2002353118A1 (en) * | 2001-12-11 | 2003-07-24 | Dor Biopharma, Inc. | Lipid particles and suspensions and uses thereof |
| AR040693A1 (es) | 2002-07-30 | 2005-04-13 | Wyeth Corp | Formulaciones parenterales |
| AU2002950713A0 (en) | 2002-08-09 | 2002-09-12 | Vital Health Sciences Pty Ltd | Carrier |
| US20050026877A1 (en) * | 2002-12-03 | 2005-02-03 | Novacea, Inc. | Pharmaceutical compositions comprising active vitamin D compounds |
| JP2006511525A (ja) * | 2002-12-13 | 2006-04-06 | ヤゴテック アーゲー | ナノ粒子状スピロノラクトン局所製剤 |
| US20050020546A1 (en) * | 2003-06-11 | 2005-01-27 | Novacea, Inc. | Pharmaceutical compositions comprising active vitamin D compounds |
| US8211448B2 (en) | 2003-07-07 | 2012-07-03 | Nares Ab | Microemulsions and its use for preventing airway diseases |
| PL1648412T3 (pl) * | 2003-07-07 | 2008-04-30 | Nares Ab | Mikroemulsje i ich zastosowanie do zapobiegania chorobom dróg oddechowych |
| US20050107465A1 (en) * | 2003-10-01 | 2005-05-19 | Papas Andreas M. | Composition for treating inflammatory bowel disease |
| KR100703872B1 (ko) * | 2003-10-10 | 2007-04-09 | 주식회사 삼양사 | 양친성 블록 공중합체 및 이를 포함하는 약물 전달용고분자 조성물 |
| WO2005042539A1 (en) | 2003-10-29 | 2005-05-12 | Sonus Pharmaceuticals, Inc. | Tocopherol-modified therapeutic drug compounds |
| US20060003002A1 (en) * | 2003-11-03 | 2006-01-05 | Lipocine, Inc. | Pharmaceutical compositions with synchronized solubilizer release |
| WO2005065185A2 (en) * | 2003-12-24 | 2005-07-21 | Collegium Pharmaceuticals, Inc. | Temperature-stable formulations, and methods of development thereof |
| GB0400804D0 (en) | 2004-01-14 | 2004-02-18 | Innoscience Technology Bv | Pharmaceutical compositions |
| KR100582604B1 (ko) | 2004-06-16 | 2006-05-23 | 보람제약주식회사 | 항산화제를 포함한 이부프로펜 및 덱시부프로펜의마이크로 에멀젼과 이를 이용한 투명 액제 및 투명연질캡슐 제제 |
| AU2005269800B8 (en) * | 2004-07-19 | 2011-12-01 | Jazz Pharmaceuticals Therapeutics, Inc. | Particulate constructs for release of active agents |
| CN1925853B (zh) * | 2004-07-28 | 2011-01-26 | 陈献 | 琥珀酸α-生育酚酯及其类似物和盐的稳定注射组合物 |
| US20060045865A1 (en) * | 2004-08-27 | 2006-03-02 | Spherics, Inc. | Controlled regional oral delivery |
| WO2006036614A2 (en) * | 2004-09-24 | 2006-04-06 | Boehringer Ingelheim Pharmaceuticals, Inc. | A new class of surfactant-like materials comprising vitamin e tpgs and a water soluble polymer |
| US9993558B2 (en) | 2004-10-01 | 2018-06-12 | Ramscor, Inc. | Sustained release eye drop formulations |
| US20060231309A1 (en) * | 2005-03-23 | 2006-10-19 | Lashua John A | Ergonomic plow control system |
| US20060240051A1 (en) * | 2005-04-26 | 2006-10-26 | Singleton Andy H | Eutectic blends containing a water soluble vitamin derivative |
| US9168216B2 (en) | 2005-06-17 | 2015-10-27 | Vital Health Sciences Pty. Ltd. | Carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof |
| US20070087055A1 (en) * | 2005-10-14 | 2007-04-19 | David Jan | Directly compressible extended release alprazolam formulation |
| US8679545B2 (en) | 2005-11-12 | 2014-03-25 | The Regents Of The University Of California | Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract |
| US8497258B2 (en) * | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| US20070167422A1 (en) * | 2006-01-18 | 2007-07-19 | Yu Kwok S | Pharmaceutical compositions comprising 17-allylamino-17-demethoxygeldanamycin |
| TW200824693A (en) * | 2006-08-28 | 2008-06-16 | Jazz Pharmaceuticals Inc | Pharmaceutical compositions of clonazepam and methods of use thereof |
| US20080275030A1 (en) | 2007-01-19 | 2008-11-06 | Sveinbjorn Gizurarson | Methods and Compositions for the Delivery of a Therapeutic Agent |
| EP2152274A4 (de) * | 2007-05-07 | 2010-07-21 | Questor Pharmaceuticals Inc | Nasale verabreichung von benzodiazepinen |
| US8530463B2 (en) * | 2007-05-07 | 2013-09-10 | Hale Biopharma Ventures Llc | Multimodal particulate formulations |
| ES2667945T3 (es) | 2007-10-08 | 2018-05-16 | Aurinia Pharmaceuticals Inc. | Composiciones oftálmicas que comprenden inhibidores de calcineurina o Inhibidores de mTOR |
| CA2718416C (en) * | 2008-03-13 | 2018-01-02 | Mallinckrodt Inc. | Multi-function, foot-activated controller for imaging system |
| PL2268160T3 (pl) * | 2008-03-20 | 2013-05-31 | Virun Inc | Emulsje zawierające pochodną PEG tokoferolu |
| BRPI0909185A2 (pt) | 2008-03-20 | 2015-08-25 | Virun Inc | Derivado de vitamina e e seus usos |
| EP2271214B1 (de) * | 2008-03-28 | 2017-05-03 | Particle Sciences, Inc. | Pharmazeutische lösungen und verfahren zur auflösung von therapeutika |
| US20090258865A1 (en) | 2008-03-28 | 2009-10-15 | Hale Biopharma Ventures, Llc | Administration of benzodiazepine compositions |
| US20100041622A1 (en) * | 2008-08-13 | 2010-02-18 | Bromley Philip J | Compositions containing aminoalkanes and aminoalkane derivatives |
| US8236768B2 (en) | 2008-10-03 | 2012-08-07 | 3B Pharmaceuticals, Inc. | Topical antiviral formulations |
| US11304960B2 (en) | 2009-01-08 | 2022-04-19 | Chandrashekar Giliyar | Steroidal compositions |
| EP2424549B1 (de) * | 2009-04-28 | 2014-04-23 | Optmed, Inc. | Zusammensetzungen und verfahren zur behandlung und prävention von urolithiasis und damit verbundenen leiden |
| EP2440185B1 (de) * | 2009-06-09 | 2015-04-08 | Aurinia Pharmaceuticals Inc. | Topische arzneimittelabgabesysteme zur ophthalmischen verwendung |
| EP2531047B1 (de) | 2010-02-05 | 2024-11-13 | Phosphagenics Limited | Träger mit einem nichtneutralisierten tocopherylphosphat |
| CA2792330C (en) | 2010-03-23 | 2017-01-03 | Virun, Inc | Nanoemulsion including a peg-derivative of vitamin e and a sucrose fatty acid ester |
| ES2829386T3 (es) | 2010-03-30 | 2021-05-31 | Phosphagenics Ltd | Parche de administración transdérmica |
| CN102232925A (zh) * | 2010-04-30 | 2011-11-09 | 中南大学 | 盐酸利多卡因透皮剂及其制备方法 |
| WO2011162802A1 (en) | 2010-06-21 | 2011-12-29 | Virun, Inc. | Compositions containing non-polar compounds |
| US20180153904A1 (en) | 2010-11-30 | 2018-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US9358241B2 (en) | 2010-11-30 | 2016-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US9034858B2 (en) | 2010-11-30 | 2015-05-19 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
| US20120148675A1 (en) | 2010-12-10 | 2012-06-14 | Basawaraj Chickmath | Testosterone undecanoate compositions |
| WO2012122586A1 (en) | 2011-03-15 | 2012-09-20 | Phosphagenics Limited | New composition |
| ES2683902T3 (es) | 2011-06-14 | 2018-09-28 | Hale Biopharma Ventures, Llc | Administración de benzodiacepina |
| WO2013077881A1 (en) | 2011-11-23 | 2013-05-30 | 3B Pharmaceuticals, Inc. | Antiviral formulations |
| FR2983731B1 (fr) * | 2011-12-07 | 2014-04-25 | Univ Paris Descartes | Emulsions topiques a base de melanges eutectiques d'anesthesiques locaux et d'acide gras |
| US10874122B2 (en) | 2012-02-10 | 2020-12-29 | Virun, Inc. | Beverage compositions containing non-polar compounds |
| ITRM20120331A1 (it) | 2012-07-12 | 2014-01-13 | Guidotti & C Spa Labor | Composizioni pediatriche orali liquide contenenti nepadutant. |
| US9351517B2 (en) | 2013-03-15 | 2016-05-31 | Virun, Inc. | Formulations of water-soluble derivatives of vitamin E and compositions containing same |
| US9693574B2 (en) | 2013-08-08 | 2017-07-04 | Virun, Inc. | Compositions containing water-soluble derivatives of vitamin E mixtures and modified food starch |
| WO2016033549A2 (en) | 2014-08-28 | 2016-03-03 | Lipocine Inc. | (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE |
| US9498485B2 (en) | 2014-08-28 | 2016-11-22 | Lipocine Inc. | Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters |
| US10016363B2 (en) | 2014-09-18 | 2018-07-10 | Virun, Inc. | Pre-spray emulsions and powders containing non-polar compounds |
| US9861611B2 (en) | 2014-09-18 | 2018-01-09 | Virun, Inc. | Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same |
| US20160361322A1 (en) | 2015-06-15 | 2016-12-15 | Lipocine Inc. | Composition and method for oral delivery of androgen prodrugs |
| WO2017011600A1 (en) | 2015-07-13 | 2017-01-19 | Dr. Reddy's Laboratories, Ltd. | Topical retinoid compositions |
| WO2017011785A1 (en) | 2015-07-15 | 2017-01-19 | National Concessions Group Inc. | Topical antiviral formulations and methods of using the same |
| US10172833B2 (en) | 2015-08-11 | 2019-01-08 | Insys Development Company, Inc. | Sublingual ondansetron spray |
| MX383940B (es) | 2015-12-09 | 2025-03-14 | Phosphagenics Ltd | Formulación farmacéutica que contiene tocol fosfato. |
| US10383833B2 (en) * | 2016-10-13 | 2019-08-20 | Milanapharm LLC | Topical formulations and treatments |
| US11559530B2 (en) | 2016-11-28 | 2023-01-24 | Lipocine Inc. | Oral testosterone undecanoate therapy |
| IL267006B2 (en) | 2016-12-21 | 2024-11-01 | Phosphagenics Ltd | Process for phosphorylation of a complex alcohol with p4o10 at high temperatures, and products thereof |
| US20190224275A1 (en) | 2017-05-12 | 2019-07-25 | Aurinia Pharmaceuticals Inc. | Protocol for treatment of lupus nephritis |
| EP3761961A4 (de) * | 2018-03-07 | 2022-01-05 | Andrew Xian Chen | Wässrige formulierungen für unlösliche arzneimittel |
| WO2020018974A1 (en) | 2018-07-20 | 2020-01-23 | Lipocine Inc. | Liver disease |
| US10799455B1 (en) | 2019-11-11 | 2020-10-13 | King Abdulaziz University | Micellles containing alpha lipoic acid as a transdermal drug delivery system |
| US10736843B1 (en) | 2019-11-22 | 2020-08-11 | King Abdulaziz University | In situ gelling composition containing tocopherol-loaded micelles as an intranasal drug delivery system |
| US11980636B2 (en) | 2020-11-18 | 2024-05-14 | Jazz Pharmaceuticals Ireland Limited | Treatment of hematological disorders |
| JP2024521399A (ja) | 2021-06-10 | 2024-05-31 | ニューレリス、インク． | 小児患者における発作性障害を治療するための組成物および方法 |
| WO2023119230A1 (en) | 2021-12-22 | 2023-06-29 | L'oreal | Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7711916A (nl) | 1977-10-29 | 1979-05-02 | Akzo Nv | Werkwijze ter bereiding van sterk geconcen- treerde farmaceutische preparaten van steroiden. |
| US4439432A (en) | 1982-03-22 | 1984-03-27 | Peat Raymond F | Treatment of progesterone deficiency and related conditions with a stable composition of progesterone and tocopherols |
| DE3405240A1 (de) | 1984-02-15 | 1985-08-22 | Roshdy Dipl.-Chem. Dr. 5000 Köln Ismail | Rheuma- und venenmittel |
| GB8501015D0 (en) | 1985-01-16 | 1985-02-20 | Riker Laboratories Inc | Drug |
| US4628052A (en) * | 1985-05-28 | 1986-12-09 | Peat Raymond F | Pharmaceutical compositions containing dehydroepiandrosterone and other anesthetic steroids in the treatment of arthritis and other joint disabilities |
| AU601176B2 (en) | 1986-03-10 | 1990-09-06 | Kurt Burghart | Benzodiazepine aerosols |
| AU620048B2 (en) | 1987-09-03 | 1992-02-13 | University Of Georgia Research Foundation, Inc., The | Ocular cyclosporin composition |
| WO1989003689A1 (en) * | 1987-10-19 | 1989-05-05 | The Liposome Company, Inc. | Tocopherol-based pharmaceutical systems |
| MX9203804A (es) * | 1987-10-19 | 1992-07-01 | Liposome Co Inc | Sistemas farmaceuticos a base de tocoferol. |
| US4847072A (en) * | 1987-10-22 | 1989-07-11 | The Procter & Gamble Company | Photoprotection compositions comprising tocopherol sorbate |
| US4960814A (en) | 1988-06-13 | 1990-10-02 | Eastman Kodak Company | Water-dispersible polymeric compositions |
| US4950664A (en) | 1988-09-16 | 1990-08-21 | Rugby-Darby Group Companies, Inc. | Nasal administration of benzodiazepine hypnotics |
| DE3908047A1 (de) | 1989-03-13 | 1990-09-20 | Desitin Arzneimittel Gmbh | Hochdisperse pharmazeutische zusammensetzung |
| AU653325B2 (en) | 1990-02-12 | 1994-09-29 | Lucky Limited | A composition durably releasing bioactive polypeptides |
| ES2097145T3 (es) | 1990-03-28 | 1997-04-01 | Noven Pharma | Metodo y dispositivo para la liberacion de farmacos en la piel. |
| ATE164080T1 (de) | 1990-05-10 | 1998-04-15 | Bechgaard Int Res | Pharmazeutische zubereitung enthaltend n- glykofurole und n-äthylenglykole |
| US5179122A (en) * | 1991-02-11 | 1993-01-12 | Eastman Kodak Company | Nutritional supplement containing vitamin e |
| US5223268A (en) | 1991-05-16 | 1993-06-29 | Sterling Drug, Inc. | Low solubility drug-coated bead compositions |
| EP0636618A1 (de) | 1991-06-04 | 1995-02-01 | Marigen S.A. | Spontan dispergierbare Konzentrate und Mikroemulsionen mit Vitamin-E-Verbindungen zur Herstellung von Arzneimitteln mit Antitumoraler Wirksamkeit |
| WO1993003720A2 (en) | 1991-08-16 | 1993-03-04 | Trevithick John R | Methods and compositions for treating sunburns |
| NZ244862A (en) | 1991-10-23 | 1995-07-26 | Block Drug Co | Use of vitamin e in topical pharmaceuticals to enhance penetration of the active agent |
| IL101387A (en) | 1992-03-26 | 1999-11-30 | Pharmos Ltd | Emulsion with enhanced topical and/or transdermal systemic effect utilizing submicron oil droplets |
| WO1993021905A1 (en) | 1992-04-23 | 1993-11-11 | Berlex Laboratories, Inc. | Bioadhesive solid mineral oil emulsion |
| JP2811036B2 (ja) | 1992-05-26 | 1998-10-15 | 参天製薬株式会社 | ビタミンｅ点眼剤 |
| KR960700753A (ko) * | 1993-03-03 | 1996-02-24 | 후지야마 아키라 | 광학 이성화 억제제(optical isomerization inhibitor) |
| DE4322826A1 (de) | 1993-07-08 | 1995-01-12 | Galenik Labor Freiburg Gmbh | Pharmazeutisches Präparat |
| DE59409377D1 (de) * | 1993-10-22 | 2000-06-29 | Hexal Ag | Pharmazeutische zusammensetzung mit cyclosporin a, einen vitamin e derivat und einen emulgator |
| KR970701535A (ko) | 1994-03-14 | 1997-04-12 | 지울리아노 페트렐리 | 비타민 E를 함유하는 에어로졸 약물 제형(Aerosol drug formulations containing vitamin'E) |
| US5430021A (en) * | 1994-03-18 | 1995-07-04 | Pharmavene, Inc. | Hydrophobic drug delivery systems |
| CN1129400A (zh) | 1994-05-06 | 1996-08-21 | 阿尔康实验室公司 | 维生素e生育酚衍生物在眼科组合物中的应用 |
-
1994
- 1994-05-16 GB GB9409778A patent/GB9409778D0/en active Pending
-
1995
- 1995-05-15 EP EP95921750A patent/EP0762896B1/de not_active Expired - Lifetime
- 1995-05-15 DK DK95921750T patent/DK0762896T3/da active
- 1995-05-15 PT PT95921750T patent/PT762896E/pt unknown
- 1995-05-15 DE DE69528057T patent/DE69528057T2/de not_active Expired - Lifetime
- 1995-05-15 NZ NZ287857A patent/NZ287857A/xx not_active IP Right Cessation
- 1995-05-15 AT AT95921750T patent/ATE223232T1/de active
- 1995-05-15 CA CA002189328A patent/CA2189328C/en not_active Expired - Fee Related
- 1995-05-15 WO PCT/EP1995/001835 patent/WO1995031217A1/en not_active Ceased
- 1995-05-15 ES ES95921750T patent/ES2178674T3/es not_active Expired - Lifetime
-
1996
- 1996-11-14 NO NO19964832A patent/NO314569B1/no not_active IP Right Cessation
- 1996-11-15 FI FI964583A patent/FI119175B/fi not_active IP Right Cessation
-
1997
- 1997-05-14 US US08/856,054 patent/US6193985B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| NO314569B1 (no) | 2003-04-14 |
| FI964583A0 (fi) | 1996-11-15 |
| FI119175B (fi) | 2008-08-29 |
| CA2189328C (en) | 2003-07-22 |
| AU2670595A (en) | 1995-12-05 |
| DK0762896T3 (da) | 2003-01-06 |
| FI964583L (fi) | 1996-11-15 |
| GB9409778D0 (en) | 1994-07-06 |
| DE69528057T2 (de) | 2003-11-06 |
| WO1995031217A1 (en) | 1995-11-23 |
| US6193985B1 (en) | 2001-02-27 |
| EP0762896B1 (de) | 2002-09-04 |
| CA2189328A1 (en) | 1995-11-23 |
| DE69528057D1 (de) | 2002-10-10 |
| ES2178674T3 (es) | 2003-01-01 |
| NO964832L (no) | 1997-01-13 |
| AU697540B2 (en) | 1998-10-08 |
| NZ287857A (en) | 1998-09-24 |
| EP0762896A1 (de) | 1997-03-19 |
| NO964832D0 (no) | 1996-11-14 |
| PT762896E (pt) | 2003-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69528057D1 (de) | Tocopherolzusammensetzungen zur Abgabe von biologisch aktiven Substanzen | |
| ATE329897T1 (de) | Verbindungen und zusammensetzungen zur verabreichung aktiven substanzen | |
| DE60038183D1 (de) | Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe | |
| ATE209491T1 (de) | Stabilisierung von säureempfindluchen benzimidazolen unter verwendung von aminosäure/cyclodextrin kombinationen | |
| CY1113609T1 (el) | ΔΙΑΛΥΤΟΤΗΤΑ ΙFΝ-ΒΗΤΑ-1b ΣΕ ΔΙΑΛΥΜΑΤΑ ΧΛΩΡΙΟΥΧΟΥ ΝΑΤΡΙΟΥ | |
| BR0116452A (pt) | Composto, composição farmacêutica, uso de um composto | |
| ATE428729T1 (de) | Kovalent verbrückte insulindimere | |
| NO971889D0 (no) | Forbindelser og sammensetninger for levering av aktive midler | |
| PT1123120E (pt) | Formulacao medicinal em aerossol | |
| DK0960107T3 (da) | 6-Thiosubstituerede paclitaxeler | |
| ES2110377T1 (es) | Formulacion galenica de fenofibrato y aplicacion de la misma. | |
| EP1226109A4 (de) | Phenylamin-carbonsäure-verbindungen und zubereitungen zur verabreichung von wirkstoffen | |
| ATE324907T1 (de) | Verbindung und arzneizusammensetzung zur verabreichung von wirkstoffen | |
| TR199903191T2 (xx) | Vorikonazol i�eren ila� form�lasyonlar�. | |
| DK0994710T4 (da) | Farmaceutiske præparater til oral indgivelse omfattende en benzylhydrylpiperazin og en cyclodextrin | |
| TR199801861T2 (xx) | Farmas�tik olarak yararl� bile�imler. | |
| ATE311373T1 (de) | Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen | |
| DE60019334D1 (de) | Antivirale arznei | |
| BR0213379A (pt) | Formulação resistente a derramamento de mascaramento de gosto | |
| ATE464878T1 (de) | Pharmazeutische zusammensetzung zur nasalen anwendung von fentanyl | |
| BR0206960A (pt) | Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose | |
| SE9403389D0 (sv) | Pharmaceutical composition containing derivattves of sex hormones | |
| SE9902742D0 (sv) | New pharmaceutical formultion | |
| TR200001055T2 (tr) | Yeni metilenbifosfonik asit türevleri | |
| ATE293635T1 (de) | Streptograminderivate, ihre herstellung und sie enthaltende zubereitungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |